Cytokinetics Inc (CYTK)
$62.99 -0.51% Close Oct 30, 2026 Live
Cytokinetics stock today
Cytokinetics closed at $62.99 on October 30, 2026, down 0.51% on the day. Over the past year it returned +1.2% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $7.84 billion.
$60.00$70.00$80.00
NovJan 2026MarMayJulSep
| Period | CYTK | S&P 500 (SPY) |
|---|---|---|
| 1 month | -4.4% | -0.9% |
| 3 months | -21.7% | +2.1% |
| Year to date | -0.9% | +11.7% |
| 1 year | +1.2% | +12.4% |
| 3 years | +96.3% | +88.5% |
| 5 years | +80.4% | +76.0% |
Key statistics
- Market value
- $7.84B
- Price / sales
- 115.8
- 52-week range
- $59.19 to $87.26
- Next report
- Nov 4, 2026
About Cytokinetics
Cytokinetics develops small molecule therapeutics for muscle diseases and cardiac conditions.
Sector: Health Care
More on Cytokinetics
- Financials: revenue, earnings and segmentsRevenue +377% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $6,467 today
No forecast, no recommendation. This page describes Cytokinetics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.